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PURPOSE  
The aim of this study was to develop a video-microscopic method to evaluate the effect of 
precipitation inhibitors (PI) on supersaturated solutions of the poorly soluble drug tadalafil using a 
novel small scale setup. 
METHODS 
A supersaturated tadalafil solution (degree of supersaturation = 29) was induced by spiking 30 µL 
of a 5 mg/mL DMSO stock into 200 µL fasted state simulated intestinal medium (FaSSIF, 
biorelevant.com) with predissolved HPMC (0-1 %w/v) as PI. The studies were performed on the 
oCelloScope SystemTM (Philips Biocell A/S, Allerød, DK) in a 96-well plate using video-microscopy 
and the precipitation was followed over time. The induction time was determined as the time point 
with the first particle in focus and the onwards growth of the particle was measured.  
RESULTS 
Without PI, the induction time was found to be 5.5 ± 1.1 minutes for tadalafil in FaSSIF (Fig. 1). 
Addition of 0.05 – 0.5 %w/v HPMC significantly prolonged the induction time (7.7 ± 0.9 to 10.5 ± 2.1 
minutes, p<0.05). Lower concentrations of HPMC (0.001 – 0.025 %w/v) did not prolong the 
induction time. The particle growth rate decreased in presence of HPMC (Fig. 1). The maximum 
inhibitory effect on growth rate was achieved at 0.01 %w/v HPMC. Higher concentrations of 
polymer (up to 0.5 %w/v) did not further decrease the growth rate. Addition of 0.001 %w/v HPMC 
did suppress the growth rate, but not to the same extent as higher concentration (0.01-0.5 %w/v). A 
clear difference was observed in particle size when comparing tadalafil particles with and without PI 
(Fig. 2).  
CONCLUSION 
Tadalafil, in presence of HPMC, shows a prolonged induction time and a reduced particle growth 
rate. Addition of 0.001 %w/v HPMC decreased the growth rate and the maximum inhibitory effect 
on growth rate was achieved with 0.01 %w/v. However, in order to also significantly prolong the 
induction time, 0.05 %w/v HPMC was needed. This method is a promising tool for comparing the 
effectiveness of PI on supersaturation of poorly soluble drugs. 
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Fig. 2: Pictures taken with the oCelloScope 
SystemTM over time. A) Precipitation of tadalafil 
in FaSSIF. B) Precipitation of tadalafil in 
FaSSIF with predissolved HPMC (0.5 %w/v). 
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Fig. 1: A) The induction time for tadalafil with 
different HPMC conc. (mean ± SD, n = 24, * = 
significantly different from 0.0 %w/v HPMC).         
B) The area of one well defined particle as a 
function of time, with different HPMC 
concentrations (mean ± SD, n = 3-24); ● 0.0%w/v, 
■ 0.001 %w/v, ▲ 0.01 %w/v, ▼ 0.025 %w/v  0.05 
%w/v,  0.1 %w/v, ● 0.25 %w/v and ■ 0.5 %w/v.  
 
